AZTA Azenta, Inc.
Nasdaq · SEC CIK 933974 · EDGAR
- Bought, last 12 months
- $171.9K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 206 since 2021-07-23, latest 2026-09-23 10:24
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Cornog William L | Dir | $163.8K | — |
| Starr Ephraim | SVP, Gen Counsel, Sec | $8,096 | — |
| Bello Erik J. | VP CAO | — | — |
| Lin Lawrence Y. | EVP, CFO, Treas | — | — |
| Pirogova Olga | SVP, CHRO | — | — |
| Koffey Quentin | Dir | — | — |
| Zhou Ginger | SVP, GM, Multiomics | — | — |
| MARTIN WILLIAM E. III | Pres Multiomics | — | — |
| Casal Frank | Dir | — | — |
| Marotta John | Pres, CEO, Dir | — | — |
Transactions 211
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-05 | 2023-12-01 | AZTA | Wang David Dong | SVP, GM, SMS | D - Sale to Iss | $57.96 | -138 | 9,478 | -1% | -$7,998 | |
| 2023-11-20 | 2023-11-17 | AZTA | Gray David C | Chief Strategy, New Business | D - Sale to Iss | $54.83 | -5,179 | 74.9K | -6% | -$284.0K | |
| M | 2023-11-17 | 2023-11-16 | AZTA | Cueto Herman | EVP, CFO | A - Grant | $54.57 | +14.9K | 14.9K | New | +$812.5K |
| 2023-11-17 | 2023-11-16 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | D - Sale to Iss | $53.81 | -12.9K | 424.1K | -3% | -$692.3K | |
| M | 2023-11-17 | 2023-11-15+ | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | A - Grant | $54.38 | +38.9K | 446.5K | +10% | +$2.11M |
| M | 2023-11-17 | 2023-11-15+ | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $54.40 | +9,057 | 107.0K | +9% | +$492.7K |
| 2023-11-17 | 2023-11-16 | AZTA | Joseph Jason | SVP, GC, Secy | D - Sale to Iss | $53.81 | -1,831 | 101.5K | -2% | -$98.5K | |
| 2023-11-17 | 2023-11-16 | AZTA | Robertson Lindon G | EVP, CFO | D - Sale to Iss | $53.81 | -2,779 | 121.1K | -2% | -$149.5K | |
| 2023-11-17 | 2023-11-15 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $54.13 | +6,297 | 123.9K | +5% | +$340.9K | |
| 2023-11-17 | 2023-11-16 | AZTA | Wang David Dong | SVP, GM, SMS | A - Grant | $54.57 | +3,207 | 9,616 | +50% | +$175.0K | |
| 2023-11-17 | 2023-11-16 | AZTA | Hughes Violetta | VP, CAO | A - Grant | $54.57 | +1,374 | 4,057 | +51% | +$75.0K | |
| 2023-11-17 | 2023-11-16 | AZTA | Pirogova Olga | SVP, CHRO | A - Grant | $54.57 | +3,207 | 3,207 | New | +$175.0K | |
| M | 2023-11-17 | 2023-11-15+ | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $54.36 | +8,689 | 29.3K | +42% | +$472.4K |
| 2023-11-17 | 2023-11-16 | AZTA | Vacha Robin | SVP, GM Life Science Products | D - Sale to Iss | $53.81 | -2,946 | 26.4K | -10% | -$158.5K | |
| M | 2023-11-17 | 2023-11-15+ | AZTA | Gray David C | Chief Strategy, New Business | A - Grant | $54.33 | +5,166 | 79.9K | +7% | +$280.6K |
| 2023-11-17 | 2023-11-16 | AZTA | Gray David C | Chief Strategy, New Business | D - Sale to Iss | $53.81 | -2,161 | 77.8K | -3% | -$116.3K | |
| M | 2023-11-17 | 2023-11-15+ | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $54.48 | +4,084 | 9,745 | +72% | +$222.5K |
| 2023-11-17 | 2023-11-16 | AZTA | Zhou Ginger | SVP, General Manager, Genom | D - Sale to Iss | $53.81 | -458 | 9,287 | -5% | -$24.6K | |
| MA | 2023-08-15 | 2023-08-10+ | AZTA | Gray David C | Chief Strategy, New Business | S - Sale | $56.63 | -21.6K | 70.6K | -23% | -$1.22M |
| 2023-08-14 | 2023-08-10 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $55.00 | -7,400 | 25.2K | -23% | -$407.0K | |
| M | 2023-08-14 | 2023-08-10+ | AZTA | Gray David C | Chief Strategy, New Business | S - Sale | $56.37 | -15.2K | 87.9K | -15% | -$856.2K |
| 2023-08-09 | 2023-08-08 | AZTA | Zane Ellen M | Dir | A - Grant | $55.78 | -18.8K | 41.1K | -31% | -$1.05M | |
| 2023-08-01 | 2023-07-31 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $39.98 | +121 | 32.6K | +0.4% | +$4,838 | |
| 2023-08-01 | 2023-07-31 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $39.98 | +105 | 117.6K | +0.1% | +$4,198 | |
| 2023-08-01 | 2023-07-31 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $39.98 | +54 | 8,868 | +0.6% | +$2,159 | |
| 2023-06-07 | 2023-06-06 | AZTA | MARTIN JOSEPH R | Dir | S - Sale | $43.07 | -2,400 | 85.2K | -3% | -$103.4K | |
| 2023-02-15 | 2023-02-13 | AZTA | McLaughlin Erica | Dir | A - Grant | $0.00 | +3,604 | 10.4K | +53% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | PUHY DOROTHY E | Dir | A - Grant | $0.00 | +3,604 | 3,604 | New | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Casal Frank | Dir | A - Grant | $0.00 | +3,604 | 5,789 | +165% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Nova Tina Susan | Dir | A - Grant | $0.00 | +3,604 | 3,604 | New | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | MARTIN JOSEPH R | Dir | A - Grant | $0.00 | +5,268 | 93.0K | +6% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Rosenblatt Michael | Dir | A - Grant | $0.00 | +3,604 | 10.6K | +52% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Davis Robyn C | Dir | A - Grant | $0.00 | +3,604 | 27.1K | +15% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Palepu Krishna G. | Dir | A - Grant | $0.00 | +3,604 | 105.4K | +4% | $0 | |
| 2023-02-15 | 2023-02-13 | AZTA | Zane Ellen M | Dir | A - Grant | $0.00 | +3,604 | 59.9K | +6% | $0 | |
| 2023-02-02 | 2023-01-31 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $46.92 | +265 | 32.5K | +0.8% | +$12.4K | |
| 2023-02-02 | 2023-01-31 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $46.92 | +279 | 117.5K | +0.2% | +$13.1K | |
| 2023-02-02 | 2023-01-31 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $46.92 | +323 | 8,814 | +4% | +$15.2K | |
| 2023-02-02 | 2023-01-31 | AZTA | Sriram Vandana | SVP Fin, Corp. Ctrl | A - Grant | $46.92 | +369 | 6,356 | +6% | +$17.3K | |
| 2023-02-02 | 2023-01-31 | AZTA | Crowley Kimberly | SVP, Chief HR Off | A - Grant | $46.92 | +177 | 7,399 | +2% | +$8,305 | |
| 2022-11-21 | 2022-11-17 | AZTA | Coyne Mitchell | SVP, GM, Life Sciences Proj | A - Grant | $0.00 | +1,889 | 1,889 | New | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Sriram Vandana | VP, Fin, Corp. Ctrl | A - Grant | $0.00 | +2,519 | 5,987 | +73% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $0.00 | +1,889 | 8,491 | +29% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $0.00 | +3,778 | 99.8K | +4% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $0.00 | +3,778 | 32.2K | +13% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | A - Grant | $0.00 | +18.9K | 420.5K | +5% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Crowley Kimberly | SVP, Chief HR Off | A - Grant | $0.00 | +2,519 | 7,222 | +54% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Gray David C | Chief Strategy, New Business | A - Grant | $0.00 | +3,148 | 92.2K | +4% | $0 | |
| 2022-11-21 | 2022-11-17 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $0.00 | +6,296 | 117.2K | +6% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Sriram Vandana | VP, Fin, Corp. Ctrl | F - Tax | $0.00 | -81 | 3,468 | -2% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | A - Grant | $0.00 | +48.6K | 427.9K | +13% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | F - Tax | $0.00 | -26.3K | 401.6K | -6% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Crowley Kimberly | SVP, Chief HR Off | F - Tax | $0.00 | -574 | 4,703 | -11% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Robertson Lindon G | EVP, CFO | F - Tax | $0.00 | -10.1K | 110.9K | -8% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $0.00 | +20.4K | 121.0K | +20% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Zhou Ginger | SVP, General Manager, Genom | F - Tax | $0.00 | -680 | 6,602 | -9% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Zhou Ginger | SVP, General Manager, Genom | A - Grant | $0.00 | +2,236 | 7,282 | +44% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | F - Tax | $0.00 | -4,535 | 96.0K | -5% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $0.00 | +10.7K | 100.5K | +12% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Gray David C | Chief Strategy, New Business | F - Tax | $0.00 | -5,235 | 89.1K | -6% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Gray David C | Chief Strategy, New Business | A - Grant | $0.00 | +10.2K | 94.3K | +12% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $0.00 | +11.1K | 34.3K | +48% | $0 | |
| 2022-11-17 | 2022-11-15 | AZTA | Vacha Robin | SVP, GM Life Science Products | F - Tax | $0.00 | -5,838 | 28.5K | -17% | $0 | |
| 2022-08-22 | 2022-08-19 | AZTA | Robertson Lindon G | EVP, CFO | P - Purchase | $57.62 | +4,350 | 100.6K | +5% | +$250.6K | |
| 2022-08-22 | 2022-08-19 | AZTA | McManus Matthew | EVP, COO | P - Purchase | $58.15 | +8,625 | 29.5K | +41% | +$501.5K | |
| 2022-08-01 | 2022-07-29 | AZTA | Sriram Vandana | VP, Fin, Corp. Ctrl | A - Grant | $57.49 | +292 | 3,549 | +9% | +$16.8K | |
| 2022-08-01 | 2022-07-29 | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $57.49 | +98 | 96.2K | +0.1% | +$5,634 | |
| 2022-08-01 | 2022-07-29 | AZTA | De Jesus Linda | Chief Commercial Off, LS | A - Grant | $57.49 | +43 | 2,764 | +2% | +$2,472 | |
| 2022-08-01 | 2022-07-29 | AZTA | Crowley Kimberly | SVP, Chief HR Off | A - Grant | $57.49 | +144 | 5,277 | +3% | +$8,279 | |
| 2022-06-09 | 2022-02-11 | AZTA | Palepu Krishna G. | Dir | A - Grant | $0.00 | +1,922 | 101.8K | +2% | $0 | |
| 2022-06-09 | 2022-02-11 | AZTA | MARTIN JOSEPH R | Dir | A - Grant | $0.00 | +2,808 | 87.7K | +3% | $0 | |
| 2022-06-09 | 2022-02-11 | AZTA | WRIGHTON MARK S | Dir | A - Grant | $0.00 | +1,922 | 111.8K | +2% | $0 | |
| 2022-06-09 | 2022-02-11 | AZTA | McLaughlin Erica | Dir | A - Grant | $0.00 | +1,922 | 6,749 | +40% | $0 | |
| D | 2022-06-09 | 2022-02-11 | AZTA | Davis Robyn C | Dir | A - Grant | $0.00 | +1,922 | 23.5K | +9% | $0 |
| 2022-06-09 | 2022-02-11 | AZTA | Zane Ellen M | Dir | A - Grant | $0.00 | +1,922 | 56.3K | +4% | $0 | |
| 2022-06-09 | 2022-02-11 | AZTA | Rosenblatt Michael | Dir | A - Grant | $0.00 | +1,922 | 6,973 | +38% | $0 | |
| 2022-06-09 | 2022-02-11 | AZTA | Casal Frank | Dir | A - Grant | $0.00 | +1,922 | 2,185 | +731% | $0 | |
| 2022-06-07 | 2022-04-12 | AZTA | Crowley Kimberly | SVP, Chief HR Off | S - Sale | $78.02 | -132 | 5,133 | -3% | -$10.3K | |
| 2022-02-03 | 2022-01-04 | AZTA | De Jesus Linda | Chief Commercial Off, LS | S - Sale | $102.59 | -191 | 2,721 | -7% | -$19.6K | |
| 2022-02-02 | 2022-01-31 | AZTA | Vacha Robin | SVP, GM Life Science Products | A - Grant | $69.29 | +285 | 23.2K | +1% | +$19.7K | |
| 2022-02-02 | 2022-01-31 | AZTA | Robertson Lindon G | EVP, CFO | J - Other | $69.29 | +189 | 96.1K | +0.2% | +$13.1K | |
| 2022-02-02 | 2022-01-31 | AZTA | Crowley Kimberly | SVP, Chief HR Off | A - Grant | $69.29 | +110 | 5,265 | +2% | +$7,622 | |
| 2022-01-10 | 2022-01-06 | AZTA | MARTIN JOSEPH R | Dir | G - Gift | $0.00 | -1,000 | 84.9K | -1% | $0 | |
| 2021-11-22 | 2021-11-19 | AZTA | Jarzynka David | Pres, Semi Solutions | S - Sale | $120.29 | -10.2K | 46.3K | -18% | -$1.23M | |
| M | 2021-11-19 | 2021-11-17 | AZTA | Robertson Lindon G | EVP, CFO | S - Sale | $119.27 | -18.3K | 99.8K | -16% | -$2.19M |
| M | 2021-11-19 | 2021-11-17 | AZTA | Jarzynka David | Pres, Semi Solutions | S - Sale | $119.27 | -13.1K | 56.5K | -19% | -$1.56M |
| M | 2021-11-19 | 2021-11-17+ | AZTA | Vacha Robin | SVP, GM BLS-Products | S - Sale | $119.17 | -15.4K | 22.9K | -40% | -$1.83M |
| A | 2021-11-19 | 2021-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | J - Other | — | 0 | 98.2K | New | — |
| M | 2021-11-19 | 2021-11-17 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | S - Sale | $119.27 | -41.4K | 386.2K | -10% | -$4.93M |
| M | 2021-11-19 | 2021-11-17+ | AZTA | Gray David C | Chief Strategy, New Business | S - Sale | $118.99 | -11.5K | 88.2K | -11% | -$1.36M |
| M | 2021-11-19 | 2021-11-17 | AZTA | Pietrantoni David | Principal Accounting Off | S - Sale | $119.27 | -4,830 | 28.2K | -15% | -$576.1K |
| M | 2021-11-19 | 2021-11-17 | AZTA | Joseph Jason | SVP, GC, Secy | S - Sale | $119.27 | -8,694 | 89.8K | -9% | -$1.04M |
| 2021-11-18 | 2021-11-15 | AZTA | Crowley Kimberly | CHRO | A - Grant | $0.00 | +1,092 | 5,155 | +27% | $0 | |
| 2021-11-17 | 2021-11-15 | AZTA | Pietrantoni David | Principal Accounting Off | A - Grant | $0.00 | +9,642 | 32.2K | +43% | $0 | |
| M | 2021-11-17 | 2021-01-31+ | AZTA | Robertson Lindon G | EVP, CFO | A - Grant | $0.00 | +37.0K | 113.9K | +48% | $0 |
| M | 2021-11-17 | 2021-11-15 | AZTA | Gray David C | Chief Strategy, New Business | A - Grant | $0.00 | +18.3K | 95.6K | +24% | $0 |
| M | 2021-11-17 | 2021-01-31+ | AZTA | Vacha Robin | SVP, GM BLS-Products | A - Grant | $0.00 | +19.7K | 37.7K | +110% | $0 |
| M | 2021-11-17 | 2021-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $0.00 | +19.3K | 98.2K | +24% | $0 |
| M | 2021-11-17 | 2021-11-15 | AZTA | SCHWARTZ STEPHEN S | CEO, Dir | A - Grant | $0.00 | +88.0K | 413.1K | +27% | $0 |
| 2021-11-17 | 2021-11-15 | AZTA | Joseph Jason | SVP, GC, Secy | A - Grant | $0.00 | +1,092 | 5,155 | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations